Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

334

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

HypertriglyceridemiaHyperlipoproteinemia Type IVHyperlipoproteinemia Type VHyperlipoproteinemia Type IIbHyperlipidemia

Interventions

DRUG

rosuvastatin

10mg or 20mg

Trial Locations (3)

Research Site, Guadalajara

Research Site, Mexico City

Research Site, Monterrey